SMITA RAMANADHAM

Allopathic & Osteopathic Physicians|Plastic Surgery EAST BRUNSWICK, NJ NPI 1548464324

General Payments — all program years on this page

$8,613.82

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 63
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $508.60 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $508.6019

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
ABBVIE INC. $243.082
REVANCE THERAPEUTICS, INC. $204.9715
Mentor Worldwide LLC $60.552

By program year

Program yearAmountRecords
2018 $287.733
2019 $748.2313
2020 $339.355
2021 $5,432.0211
2022 $487.148
2023 $810.754
2024 $508.6019

Records — PY2024 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1077614888 Mentor Worldwide LLC $38.82 06/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1077614890 Mentor Worldwide LLC $21.73 04/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105362155 ABBVIE INC. $128.07 02/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105362159 ABBVIE INC. $115.01 09/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147927201 REVANCE THERAPEUTICS, INC. $18.66 02/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147927203 REVANCE THERAPEUTICS, INC. $9.68 02/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147927205 REVANCE THERAPEUTICS, INC. $18.91 04/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147927207 REVANCE THERAPEUTICS, INC. $18.73 05/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147927209 REVANCE THERAPEUTICS, INC. $13.82 06/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147927211 REVANCE THERAPEUTICS, INC. $8.34 07/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147927213 REVANCE THERAPEUTICS, INC. $3.00 08/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147927215 REVANCE THERAPEUTICS, INC. $13.25 08/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147927217 REVANCE THERAPEUTICS, INC. $17.92 08/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147927219 REVANCE THERAPEUTICS, INC. $16.45 09/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147927221 REVANCE THERAPEUTICS, INC. $15.06 10/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147927223 REVANCE THERAPEUTICS, INC. $13.75 10/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147927225 REVANCE THERAPEUTICS, INC. $8.33 10/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147927227 REVANCE THERAPEUTICS, INC. $19.64 12/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147927229 REVANCE THERAPEUTICS, INC. $9.43 12/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.